NCT00973713View on ClinicalTrials.gov

Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol

PHASE2UnknownINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

September 30, 2011

Study Completion Date

March 31, 2012

Conditions

Cholangiocarcinoma

Interventions

DRUG

RAD001

10mg/d

Trial Locations (1)

3084

RECRUITING

Austin Health, Melbourne

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Austin Health

OTHER_GOV

NCT00973713 - Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol | Biotech Hunter | Biotech Hunter